Beth Hecht

See Remarks

Beth Hecht (See Remarks) filed 10 Form 4 reports in the trailing twelve months (0 purchases, 10 sales), most often in Xeris Biopharma Holdings, Inc. (XERS). The largest single filing was $141K of XERS (16,666 sh × $8.49, as filed), executed Sep 1.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 10 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$1.2M

shares × price, as filed

Last traded

Sep 1

Filed Sep 1

Median ADV $16.5M across their filed names

Open performance→

Volume by month

Buys $0 Sells $1.4M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 10 filings

Sector per market data · by filing · past 12 months

Most traded names

XERS Xeris Biopharma Holdings, Inc. XERS · 0 buys · 11 sells 11 filings

Recent filings

XERSSALE Xeris Biopharma Holdings, Inc. View filing → $141K
16,666 sh × $8.49
Exec Sep 1
Filed Sep 1 · 6:21 PM ET XERSSALE Xeris Biopharma Holdings, Inc. View filing → $134K
16,666 sh × $8.01
Exec Aug 3
Filed Aug 4 · 5:16 PM ET XERSSALE Xeris Biopharma Holdings, Inc. View filing → $134K
16,666 sh × $8.03
Exec Jul 1
Filed Jul 2 · 4:38 PM ET XERSSALE Xeris Biopharma Holdings, Inc. View filing → $101K
16,667 sh × $6.06
Exec Jun 1
Filed Jun 2 · 5:30 PM ET XERSSALE Xeris Biopharma Holdings, Inc. View filing → $104K
16,667 sh × $6.23
Exec May 1
Filed May 1 · 5:30 PM ET XERSSALE Xeris Biopharma Holdings, Inc. View filing → $103K
16,567 sh × $6.24
Exec Mar 2
Filed Mar 4 · 5:30 PM ET XERSSALE Xeris Biopharma Holdings, Inc. View filing → $124K
16,667 sh × $7.45
Exec Feb 2
Filed Feb 2 · 5:30 PM ET XERSSALE Xeris Biopharma Holdings, Inc. View filing → $124K
16,667 sh × $7.43
Exec Jan 2
Filed Jan 5 · 5:30 PM ET More filings →